Business Wire

Vincent Hayward, Co-founder of Actronika, Elected to the Academy of Sciences

15.1.2020 15:30:00 EET | Business Wire | Press release

Share

Like famous scientists before him, Vincent Hayward, co-founder of Actronika, a start-up specializing in haptics, has been invited to join the prestigious Academy of Sciences.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200115005407/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Vincent Hayward (Photo: Inria)

Created in 1966 by Colbert, the Academy of Sciences is made up of an assembly of scientists, chosen from among the most eminent French and foreign specialists. This showcase for French science supports research, is committed to the quality of teaching and encourages international scientific development.

Vincent Hayward, a pioneer in haptics

Winner of the 2019 Inria Grand Prize - Academy of Sciences, Vincent Hayward has already been recognized for his exceptional contribution to science with his pioneering work in haptics, the discipline that explores and exploits the sense of touch.
His interest in haptics appeared in 1991 when he was interested in the accessibility of machine interfaces to visually impaired people. The generalization of graphical interfaces effectively leaves those who are visually impaired on the sidelines. The idea was to make these interfaces accessible through hearing and touch. He developed a robot called a pantograph. This force feedback device allows you to explore the screen and touch digital objects. The quality of the results and the minimal means necessary to implement the device made for an impressive experience.
Vincent discovered a valuable subject of work and became one of the founders of an almost-unexplored research domain.
After Sorbonne - Université offered him a chair in haptics in 2007, he determined the foundations for a theory explaining how touch works.

Actronika: Results of his research

Throughout these years, his research work and his involvement in numerous national and international projects are coupled with great productivity in engineering. He designed numerous devices to stimulate the skin which will give rise to dozens of patents and the creation of the start-up Actronika.
Actronika offers haptic solutions capable of producing textures and high definition effects that can be integrated into any device: smartphones, car screens, VR accessories ... It becomes possible, for example, to materialize icons on the screen of your smartphone or create 3D buttons without bulky mechanical integration.
In the digital era, Vincent Hayward reintroduces touch and revolutionizes human-machine interactions to offer users exceptional multisensory experiences.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Marina CRIFAR, Communications Manager / marina.crifar@actronika.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota4.2.2026 23:30:00 EET | Press release

Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. The policy went into effect in January 2026 and specifies that ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. “We are pleased that another Blue Cross Blue Shield payer has joined Anthem in making ReActiv8 available to well-selected patients after reviewing the large body of clinical evidence we have built,”said Jason Hannon, CEO of Mainstay Medical. “Patients with intractable chronic low back pain are desperately seeking durable solutions, and ReActiv8 has proven to be a safe and effective solution through six clinical studies with 633 patients treated and 1,950 patient-years of follow-up, including two multi-center, randomized controlled clinical studies. We look forward to

Kinaxis Inc. to Host Fourth Quarter 2025 Financial Results Conference Call on March 5, 20264.2.2026 23:30:00 EET | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in supply chain orchestration, today announced that it has scheduled its conference call to discuss the financial results for its fourth quarter and year ended December 31, 2025. The call will be hosted on Thursday, March 5 at 8:30 a.m. Eastern Time by Razat Gaurav, chief executive officer, and Blaine Fitzgerald, chief financial officer, followed by a question and answer period. The Company will report its financial results for the fourth quarter and year after the close of markets on Wednesday, March 4, 2026. CONFERENCE CALL DETAILS DATE: Thursday, March 5, 2026 TIME: 8:30 a.m. Eastern Time WEBCAST: https://events.q4inc.com/attendee/567578009 (available for three months) About Kinaxis Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that

Multi-Color Corporation Receives Court Approval of First Day Motions4.2.2026 22:30:00 EET | Press release

Multi-Color Corporation (“MCC” or the “Company”), a global leader in prime label solutions, today announced that it has received approval from the U.S. Bankruptcy Court for the District of New Jersey (the “Court”) for first day relief related to its prepackaged Chapter 11 filed on January 29, 2026. The approved relief affirms that the Company will operate in the normal course, pay all trade vendors and suppliers in full, and maintain a strong liquidity position during the restructuring. As part of this relief, the Court granted MCC immediate access to $125 million of $250 million in debtor-in-possession (“DIP”) new money financing, provided by certain holders of MCC’s secured first lien debt and its equity sponsor, CD&R. This funding will capitalize the business through the initial stages of the prepackaged Chapter 11 process. The Court also granted MCC authority to pay trade vendors and suppliers in full in the ordinary course, maintain wages and benefits without interruption, satisfy

InterSystems Honored with Four 2026 Best in KLAS Awards4.2.2026 19:00:00 EET | Press release

InterSystems, a creative data technology provider powering more than one billion health records globally, today announced it has received four Global 2026 Best in KLAS awards. The company earned a #1 ranking for Acute Care EHR in Asia, Oceania, and France, as well as for Shared Care Records in Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260204241673/en/ InterSystems earns four Best in KLAS awards for 2026 Best in KLAS is KLAS Research’s annual recognition of top-performing healthcare technology and services solutions, based entirely on feedback from healthcare provider organizations. Awards are given within defined software and services market segments evaluated by KLAS Research using a standardized methodology that reflects customer experience and performance. In addition to U.S. market segments, KLAS also recognizes top-performing solutions through its Global (Non-U.S.) Best in KLAS Awards, which are based on fe

Onego Bio Strengthens Board with Appointment of Dr. Antti Vasara4.2.2026 17:00:00 EET | Press release

Onego Bio, the food ingredient company producing non-animal egg protein through precision fermentation, today announced that Dr. Antti Vasara has joined its board of directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260204881159/en/ Dr. Antti Vasara Dr. Vasara brings more than 25 years of global experience in science, technology, and commercial strategy. Most recently, he served as President and CEO of VTT Technical Research Centre of Finland, where he led one of Europe’s foremost deep tech research organizations. His distinguished career spans senior leadership roles in industry and innovation policy—including impactful work with Nokia and strategic contributions to European research and development initiatives. “Antti is one of the most respected leaders in science and innovation,” said Maija Itkonen, CEO of Onego Bio. “His deep understanding of technology commercialization and ecosystem level strategy will be inva

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye